Literature DB >> 34173859

Determining the optimal number of lung ultrasound zones to monitor COVID-19 patients: can we keep it ultra-short and ultra-simple?

Micah L A Heldeweg1,2, Arthur W E Lieveld3,4,5, Harm J de Grooth3, Leo M A Heunks3, Pieter R Tuinman3,4.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 34173859      PMCID: PMC8233591          DOI: 10.1007/s00134-021-06463-6

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
With much interest, we read the correspondence from Mento and colleagues, as well as the original study by Volpicelli and colleagues [1, 2]. We would like to contribute original study results to move the discourse on optimal lung ultrasound methodology forward. Although the work by Mento provides an interesting perspective, we believe that the method used to study agreement between lung ultrasound protocols may have inherently led to the presented conclusions. The authors compare the proportion of worst lung ultrasound scores (LUS) across different protocols with a subjectively selected 14-zone protocol as reference standard. First, whether the reference standard accurately represents total pulmonary involvement is uncertain. In fact, previous research has shown equivalence of both 6- or 12-zone protocols compared to gold standard chest computed tomography (CT) [3, 4]. Second, the 14-zone protocol’s overrepresentation of posterior zones (43%) constitutes a scan-location bias, which is problematic when examining disease with gravity-dependent distribution. Consequently, comparing worst scores of predominantly posterior LUS protocol to worst scores of predominantly lateral or anterior LUS protocols inevitably leads to lower agreement. Third, exclusively evaluating worst LUS disregards a plethora of particulars needed to assess true agreement between protocols. We present the results of a study with robust methods to comprehensively evaluate agreement between LUS protocols. We performed a prospective observational study at the tertiary intensive care unit of the Amsterdam University Medical Centers, location VUmc. The study was approved by the local ethics board and need for informed consent was waived. A total of 191 examinations from 102 critically ill patients (81.4% male; mean age 64.9 ± 11.4) affected by coronavirus disease 2019 (COVID-19) were examined and analyzed. Full methodology is described in Supplementary S1. Reference test was a 12-zone LUS protocol which has shown to have monitoring equivalence to CT and index test was a 6-zone LUS protocol (Fig. 1A) [4]. Each LUS zone was scored from 0 (A-pattern) to 3 (consolidation). A LUS index (LUSI = (LUS/LUS achievable) × 100) was calculated for both.
Fig. 1

Lung ultrasound reference standard (blue) and index test (asterix) (a), and the Bland–Altman plot (b). Each point represents agreement between the index and reference test in one examination in one patient. A jitter effect was added to improve visualization of data and avoid direct overlap of multiple examinations. LoA Limits of Agreement, LUSI lung ultrasound score index—the lung ultrasound score expressed as a percentage of total score achievable

Agreement was tested using Spearman’s correlation coefficient, Bland–Altman plot, and smallest detectable change with accompanying 95% confidence intervals (Supplementary S2). The Spearman’s correlation coefficient was 0.944, indicating a strong correlation. The Bland–Altman plot (Fig. 1B) exhibited a constant bias, indicating that 6-zone LUS was consistently 1.9% (95% CI 1.1%, 2.7%) higher than 12-zone LUS. No proportional bias was found, signifying that imaging protocols agreed equally across disease severities. The limits of agreement of 10.8% (95% CI 7.4%, 14.2%) were smaller than the calculated smallest detectable change of 17.4% (95% CI 11.8%, 26.1%) (p = 0.019, derived from 10,000 bootstrapped comparisons), indicating that differences between protocols were smaller than the measurement error (comparing each protocol to itself would have led to similar limits of agreement). Lung ultrasound reference standard (blue) and index test (asterix) (a), and the Bland–Altman plot (b). Each point represents agreement between the index and reference test in one examination in one patient. A jitter effect was added to improve visualization of data and avoid direct overlap of multiple examinations. LoA Limits of Agreement, LUSI lung ultrasound score index—the lung ultrasound score expressed as a percentage of total score achievable Monitoring COVID-19 with more than six zones does not appear to provide additional clinical information. This is important, because much of lung ultrasound’s value is owed to its efficient bedside applicability, particularly in time and resource strained settings, such as the COVID-19 pandemic. Although these results need to be validated comprehensively, this study agrees with previous investigations concerning optimal number of lung ultrasound zones: less is more [5]. Below is the link to the electronic supplementary material. Supplementary file1 (DOCX 18 KB)
  5 in total

1.  Six versus eight and twenty-eight scan sites for B-line assessment: differences in examination time and findings.

Authors:  Eline G M Cox; Renske Wiersema; Adrian Wong; Iwan C C van der Horst
Journal:  Intensive Care Med       Date:  2020-03-19       Impact factor: 17.440

2.  Limiting the areas inspected by lung ultrasound leads to an underestimation of COVID-19 patients' condition.

Authors:  Federico Mento; Tiziano Perrone; Anna Fiengo; Francesco Tursi; Veronica Narvena Macioce; Andrea Smargiassi; Riccardo Inchingolo; Libertario Demi
Journal:  Intensive Care Med       Date:  2021-05-11       Impact factor: 17.440

3.  The diagnostic accuracy for ARDS of global versus regional lung ultrasound scores - a post hoc analysis of an observational study in invasively ventilated ICU patients.

Authors:  Luigi Pisani; Veronica Vercesi; Patricia S I van Tongeren; Wim K Lagrand; Stije J Leopold; Mischa A M Huson; Patricia C Henwood; Andrew Walden; Marry R Smit; Elisabeth D Riviello; Paolo Pelosi; Arjen M Dondorp; Marcus J Schultz
Journal:  Intensive Care Med Exp       Date:  2019-07-25

4.  Lung ultrasound and computed tomography to monitor COVID-19 pneumonia in critically ill patients: a two-center prospective cohort study.

Authors:  Micah L A Heldeweg; Jorge E Lopez Matta; Mark E Haaksma; Jasper M Smit; Carlos V Elzo Kraemer; Harm-Jan de Grooth; Evert de Jonge; Lilian J Meijboom; Leo M A Heunks; David J van Westerloo; Pieter R Tuinman
Journal:  Intensive Care Med Exp       Date:  2021-01-25

5.  Lung ultrasound for the early diagnosis of COVID-19 pneumonia: an international multicenter study.

Authors:  Giovanni Volpicelli; Luna Gargani; Stefano Perlini; Stefano Spinelli; Greta Barbieri; Antonella Lanotte; Gonzalo García Casasola; Ramon Nogué-Bou; Alessandro Lamorte; Eustachio Agricola; Tomas Villén; Paramjeet Singh Deol; Peiman Nazerian; Francesco Corradi; Valerio Stefanone; Denise Nicole Fraga; Paolo Navalesi; Robinson Ferre; Enrico Boero; Giampaolo Martinelli; Lorenzo Cristoni; Cristiano Perani; Luigi Vetrugno; Cian McDermott; Francisco Miralles-Aguiar; Gianmarco Secco; Caterina Zattera; Francesco Salinaro; Alice Grignaschi; Andrea Boccatonda; Fabrizio Giostra; Marta Nogué Infante; Michele Covella; Giacomo Ingallina; Julia Burkert; Paolo Frumento; Francesco Forfori; Lorenzo Ghiadoni
Journal:  Intensive Care Med       Date:  2021-03-20       Impact factor: 17.440

  5 in total
  3 in total

1.  Lung ultrasound to predict gas-exchange response to prone positioning in COVID-19 patients: A prospective study in pilot and confirmation cohorts.

Authors:  M L A Heldeweg; A Mousa; J van Ekeren; A W E Lieveld; R S Walburgh-Schmidt; J M Smit; M E Haaksma; H J de Grooth; L M A Heunks; P R Tuinman
Journal:  J Crit Care       Date:  2022-10-17       Impact factor: 4.298

2.  Reliability and clinical correlations of semi-quantitative lung ultrasound on BLUE points in COVID-19 mechanically ventilated patients: The 'BLUE-LUSS'-A feasibility clinical study.

Authors:  Gábor Orosz; Pál Gyombolai; József T Tóth; Marcell Szabó
Journal:  PLoS One       Date:  2022-10-14       Impact factor: 3.752

Review 3.  Lung Ultrasound: A Diagnostic Leading Tool for SARS-CoV-2 Pneumonia: A Narrative Review.

Authors:  Luigi Maggi; Anna Maria Biava; Silvia Fiorelli; Flaminia Coluzzi; Alberto Ricci; Monica Rocco
Journal:  Diagnostics (Basel)       Date:  2021-12-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.